Fady Ibraham Malik - 10 Mar 2022 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Fady Malik
Issuer symbol
RCKT
Transactions as of
10 Mar 2022
Net transactions value
$0
Form type
4
Filing time
11 Mar 2022, 18:14:23 UTC
Previous filing
08 Mar 2022
Next filing
07 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +33,199 $0.000000 33,199 10 Mar 2022 Common Stock 33,199 $16.65 Direct F1
transaction RCKT Stock Option (Right to Buy) Award $0 +8,641 $0.000000 8,641 10 Mar 2022 Common Stock 8,641 $16.65 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 33,199 shares of the Issuer's common stock, which will vest in equal monthly installments over a three-year period, such that all of the shares underlying this option will be fully vested on March 10, 2025.
F2 This option represents a right to purchase a total of 8,641 shares of the Issuer's common stock, which will fully vest on March 10, 2024.